Maravai LifeSciences Holdings, Inc. (MRVI) Admits to Incorrect Revenue Recognition, Ineffective Internal Controls; Class Action Pending – Hagens Berman
Maravai LifeSciences Holdings, Inc. - Class A common stock (MRVI)
Company Research
Source: GlobeNewswire
SAN FRANCISCO, April 04, 2025 (GLOBE NEWSWIRE) -- On Mar. 19, 2025, the price of Maravai LifeSciences (NASDAQ: MRVI) shares fell almost 6% after the company warned investors against relying on previously filed financial statements. This move lower follows a 21% drop on Feb. 25, 2025 after the company postponed its Q4 and FY 2024 earnings release and investor conference call. A class action lawsuit has been filed against Maravai, a global provider of life science reagents and services to researchers and biotech innovators. The suit, captioned Nelson v. Maravai Lifesciences Holdings, Inc., et al., No. 3:25-cv-00499-AGS-AHG (S.D. Cal.), represents investors who purchased Maravai securities between August 7, 2024 and February 24, 2025. Hagens Berman is investigating the alleged claims and urges Maravai investors who suffered substantial losses to submit your losses now. Class Period: Aug. 7, 2024 – Feb. 24, 2025Lead Plaintiff Deadline: May 5, 2025Visit: www.hbsslaw.com/investor-fraud
Show less
Read more
Impact Snapshot
Event Time:
MRVI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRVI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRVI alerts
High impacting Maravai LifeSciences Holdings, Inc. - Class A common stock news events
Weekly update
A roundup of the hottest topics
MRVI
News
- Maravai LifeSciences (NASDAQ:MRVI) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.MarketBeat
- Why Analysts See Opportunity and Risk as Maravai's Story Evolves After Management Shakeup [Yahoo! Finance]Yahoo! Finance
- CEO & Director of Maravai LifeSciences Holdings Picks Up 13% More Stock [Yahoo! Finance]Yahoo! Finance
- Maravai LifeSciences Announces November 2025 Investor Conference ScheduleBusiness Wire
- Maravai LifeSciences Reports Third Quarter 2025 Financial ResultsBusiness Wire
MRVI
Earnings
- 11/6/25 - In-Line
MRVI
Sec Filings
- 12/19/25 - Form 144
- 12/9/25 - Form 4
- 11/18/25 - Form 4
- MRVI's page on the SEC website